AHCOAdaptHealth Corp.

Nasdaq adapthealth.com


$ 11.33 $ -0.16 (-1.39 %)    

Wednesday, 18-Sep-2024 15:59:58 EDT
QQQ $ 472.49 $ -2.05 (-0.43 %)
DIA $ 416.26 $ -1.07 (-0.26 %)
SPY $ 562.20 $ -1.67 (-0.3 %)
TLT $ 99.62 $ -1.25 (-1.24 %)
GLD $ 235.53 $ -1.83 (-0.77 %)
$ 11.33
$ 11.42
$ 11.32 x 200
-- x --
$ 11.32 - $ 11.69
$ 6.37 - $ 11.90
1,202,134
na
1.52B
$ 0.84
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-07-2024 03-31-2024 10-Q
3 02-27-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 02-28-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-09-2022 06-30-2022 10-Q
10 05-10-2022 03-31-2022 10-Q
11 03-01-2022 12-31-2021 10-K
12 11-09-2021 09-30-2021 10-Q
13 08-06-2021 06-30-2021 10-Q
14 05-10-2021 03-31-2021 10-Q
15 03-16-2021 12-31-2020 10-K
16 11-06-2020 09-30-2020 10-Q
17 08-07-2020 06-30-2020 10-Q
18 05-08-2020 03-31-2020 10-Q
19 03-06-2020 12-31-2019 10-K
20 11-05-2019 09-30-2019 10-Q
21 07-31-2019 06-30-2019 10-Q
22 05-14-2019 03-31-2019 10-Q
23 03-29-2019 12-31-2018 10-K
24 11-08-2018 09-30-2018 10-Q
25 08-08-2018 06-30-2018 10-Q
26 05-15-2018 03-31-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 rbc-capital-reiterates-outperform-on-adapthealth-maintains-13-price-target

RBC Capital analyst Ben Hendrix reiterates AdaptHealth (NASDAQ:AHCO) with a Outperform and maintains $13 price target.

 adapthealth-q2-2024-adj-eps-013-misses-016-estimate-sales-80600m-beat-80263m-estimate

AdaptHealth (NASDAQ:AHCO) reported quarterly earnings of $0.13 per share which missed the analyst consensus estimate of $0.16 b...

 adapthealth-appoints-dale-wolf-as-chair-of-board-effective-july-1-2024

Wolf has served on AdaptHealth's Board since November 2019 and will assume the role from outgoing Chairman Richard Barasch....

 truist-securities-maintains-buy-on-adapthealth-maintains-13-price-target

Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and maintains $13 price target.

 adapthealth-q1-2024-gaap-eps-002-may-not-be-comparable-to-005-estimate-sales-792497m-beat-769867m-estimate

AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.05 b...

 adapthealth-appoints-suzanne-foster-as-chief-executive-officer-will-assume-leadership-of-the-company-from-interim-ceo-and-chairman-of-the-board-richard-barasch-on-may-20-2024

AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-center...

 rbc-capital-reiterates-outperform-on-adapthealth-maintains-13-price-target

RBC Capital analyst Ben Hendrix reiterates AdaptHealth (NASDAQ:AHCO) with a Outperform and maintains $13 price target.

 ubs-maintains-buy-on-adapthealth-raises-price-target-to-13

UBS analyst Whit Mayo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $9 to $13.

 truist-securities-maintains-buy-on-adapthealth-raises-price-target-to-13

Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $1...

 why-helix-energy-solutions-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

 norwegian-cruise-line-posts-strong-sales-joins-hims--hers-health-sterling-infrastructure-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Tuesday.

 earnings-scheduled-for-february-27-2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

 ubs-maintains-buy-on-adapthealth-lowers-price-target-to-9

UBS analyst Whit Mayo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $10 to $9.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION